MRAI Stock Overview
Operates as a technology-driven healthcare payer company in the United States. More details
| Snowflake Score | |
|---|---|
| Valuation | 2/6 |
| Future Growth | 0/6 |
| Past Performance | 0/6 |
| Financial Health | 0/6 |
| Dividends | 0/6 |
Community vs My Fair Value
Create NarrativeSelect a narrative for quick price alerts from the community, or create your own.
Marpai, Inc. Competitors
Price History & Performance
| Historical stock prices | |
|---|---|
| Current Share Price | US$1.30 |
| 52 Week High | US$2.35 |
| 52 Week Low | US$0.40 |
| Beta | 4.72 |
| 1 Month Change | 54.76% |
| 3 Month Change | 36.84% |
| 1 Year Change | -42.22% |
| 3 Year Change | -69.05% |
| 5 Year Change | n/a |
| Change since IPO | -93.16% |
Recent News & Updates
Recent updates
Revenues Not Telling The Story For Marpai, Inc. (NASDAQ:MRAI) After Shares Rise 30%
Apr 07
Investors Still Aren't Entirely Convinced By Marpai, Inc.'s (NASDAQ:MRAI) Revenues Despite 34% Price Jump
Feb 16Market Might Still Lack Some Conviction On Marpai, Inc. (NASDAQ:MRAI) Even After 106% Share Price Boost
Dec 19Not Many Are Piling Into Marpai, Inc. (NASDAQ:MRAI) Stock Yet As It Plummets 28%
Jun 29Marpai rallies after directors buy shares
Aug 19Marpai to acquire Maestro Health for $22.1M
Aug 04Shareholder Returns
| MRAI | US Insurance | US Market | |
|---|---|---|---|
| 7D | 23.8% | 0.6% | 0.3% |
| 1Y | -42.2% | 16.7% | 8.0% |
Return vs Industry: MRAI underperformed the US Insurance industry which returned 16.7% over the past year.
Return vs Market: MRAI underperformed the US Market which returned 8% over the past year.
Price Volatility
| MRAI volatility | |
|---|---|
| MRAI Average Weekly Movement | 16.0% |
| Insurance Industry Average Movement | 5.4% |
| Market Average Movement | 8.0% |
| 10% most volatile stocks in US Market | 16.6% |
| 10% least volatile stocks in US Market | 4.2% |
Stable Share Price: MRAI's share price has been volatile over the past 3 months compared to the US market.
Volatility Over Time: MRAI's weekly volatility has decreased from 25% to 16% over the past year, but is still higher than 75% of US stocks.
About the Company
| Founded | Employees | CEO | Website |
|---|---|---|---|
| 2021 | 117 | Damien Lamendola | www.marpaihealth.com |
Marpai, Inc., together with its subsidiaries, operates as a technology-driven healthcare payer company in the United States. The company offers third-party administrator and value-oriented health plan services to employers that directly pay for employee health benefits. It also provides in-house ancillary services that include clinical care management, a nurse-led guide for at-risk members across the care continuum; repricing insights, which are out-of-network claims; Marpai PACCS, a pharmacy advocacy cost containment solution that is a member-driven pharmacy savings program; and MarpaiRx, a national pharmacy benefit management program.
Marpai, Inc. Fundamentals Summary
| MRAI fundamental statistics | |
|---|---|
| Market cap | US$19.37m |
| Earnings (TTM) | -US$22.09m |
| Revenue (TTM) | US$28.17m |
0.7x
P/S Ratio-0.9x
P/E RatioIs MRAI overvalued?
See Fair Value and valuation analysisEarnings & Revenue
| MRAI income statement (TTM) | |
|---|---|
| Revenue | US$28.17m |
| Cost of Revenue | US$19.07m |
| Gross Profit | US$9.11m |
| Other Expenses | US$31.20m |
| Earnings | -US$22.09m |
Last Reported Earnings
Dec 31, 2024
Next Earnings Date
May 14, 2025
| Earnings per share (EPS) | -1.48 |
| Gross Margin | 32.33% |
| Net Profit Margin | -78.40% |
| Debt/Equity Ratio | -114.5% |
How did MRAI perform over the long term?
See historical performance and comparisonCompany Analysis and Financial Data Status
| Data | Last Updated (UTC time) |
|---|---|
| Company Analysis | 2025/05/12 08:32 |
| End of Day Share Price | 2025/05/09 00:00 |
| Earnings | 2024/12/31 |
| Annual Earnings | 2024/12/31 |
Data Sources
The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.
| Package | Data | Timeframe | Example US Source * |
|---|---|---|---|
| Company Financials | 10 years |
| |
| Analyst Consensus Estimates | +3 years |
|
|
| Market Prices | 30 years |
| |
| Ownership | 10 years |
| |
| Management | 10 years |
| |
| Key Developments | 10 years |
|
* Example for US securities, for non-US equivalent regulatory forms and sources are used.
Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more.
Analysis Model and Snowflake
Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.
Learn about the world class team who designed and built the Simply Wall St analysis model.
Industry and Sector Metrics
Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on Github.
Analyst Sources
Marpai, Inc. is covered by 3 analysts. 0 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.
| Analyst | Institution |
|---|---|
| Allen Klee | Maxim Group |
| null null | Maxim Group |
| Ashok Kumar | ThinkEquity LLC |